Tumor-Derived PGE2 Gives NK Cells a Headache.

Abstract excerpt

Tumors use active immunosuppressive mechanisms to evade immune recognition and shape the local inflammatory environment. In this issue of Immunity, Bonavita et al. report that tumor-derived PGE2 blocks early activation of natural killer cells and interferes with subsequent adaptive immune cell recruitment to the tumor.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dinoprostone
• Share to Headache
• Share to Immune Checkpoint Inhibitors